636 related articles for article (PubMed ID: 29294256)
1. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.
Jin M; Wang L; Wu Y; Zang BX; Tan L
Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256
[TBL] [Abstract][Full Text] [Related]
2. Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice.
Jin M; Wu Y; Wang L; Zang B; Tan L
Phytother Res; 2016 Apr; 30(4):577-87. PubMed ID: 26777519
[TBL] [Abstract][Full Text] [Related]
3. Hydroxysafflor yellow A alleviates early inflammatory response of bleomycin-induced mice lung injury.
Wu Y; Wang L; Jin M; Zang BX
Biol Pharm Bull; 2012; 35(4):515-22. PubMed ID: 22466555
[TBL] [Abstract][Full Text] [Related]
4. Hydroxysafflor Yellow A Alleviates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Mice.
Zhang Y; Song L; Pan R; Gao J; Zang BX; Jin M
Biol Pharm Bull; 2017; 40(2):135-144. PubMed ID: 28154251
[TBL] [Abstract][Full Text] [Related]
5. Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway.
Song C; He L; Zhang J; Ma H; Yuan X; Hu G; Tao L; Zhang J; Meng J
J Cell Mol Med; 2016 Nov; 20(11):2064-2077. PubMed ID: 27306439
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory action of hydroxysafflor yellow A on inflammatory signal transduction pathway related factors in rats with cerebral cortex ischemia].
Chen TT; Du YJ; Liu XL; Zhu HB
Yao Xue Xue Bao; 2008 Jun; 43(6):570-5. PubMed ID: 18822957
[TBL] [Abstract][Full Text] [Related]
7. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
Pan R; Zhang Y; Zang B; Tan L; Jin M
J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
[TBL] [Abstract][Full Text] [Related]
8. The ability of hydroxysafflor yellow a to attenuate lipopolysaccharide-induced pulmonary inflammatory injury in mice.
Sun CY; Pei CQ; Zang BX; Wang L; Jin M
Phytother Res; 2010 Dec; 24(12):1788-95. PubMed ID: 20564507
[TBL] [Abstract][Full Text] [Related]
9. Protective Effect of Hydroxysafflor Yellow A on Inflammatory Injury in Chronic Obstructive Pulmonary Disease Rats.
Jin M; Xue CJ; Wang Y; Dong F; Peng YY; Zhang YD; Zang BX; Tan L
Chin J Integr Med; 2019 Oct; 25(10):750-756. PubMed ID: 30588579
[TBL] [Abstract][Full Text] [Related]
10. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
11. [Protective effect of hydroxysafflor yellow A against acute lung injury induced by oleic acid and lipopolysaccharide in rats].
Wang XF; Jin M; Tong J; Wu W; Li JR; Zang BX
Yao Xue Xue Bao; 2010 Jul; 45(7):940-4. PubMed ID: 20931796
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of hydroxysafflor yellow A against PMN activation induced by LPS].
Wu W; Jin M; Tong J; Wang XF; Zang BX
Yao Xue Xue Bao; 2011 Feb; 46(2):153-7. PubMed ID: 21542285
[TBL] [Abstract][Full Text] [Related]
13. Hydroxysafflor yellow A attenuates the expression of inflammatory cytokines in acute soft tissue injury.
Dong F; Xue C; Wang Y; Peng Y; Zhang Y; Jin M; Zang B
Sci Rep; 2017 Jan; 7():40584. PubMed ID: 28074914
[TBL] [Abstract][Full Text] [Related]
14. Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis.
Zhang Y; Guo J; Dong H; Zhao X; Zhou L; Li X; Liu J; Niu Y
Eur J Pharmacol; 2011 Jun; 660(2-3):438-44. PubMed ID: 21536026
[TBL] [Abstract][Full Text] [Related]
15. [The Study of the Effect and Mechanism of Glucagon Like Peptide-1 in Bleomycin-induced Pulmonary Fibrosis in Mice].
Liu M; Gou S; Chen HT; Chen ZH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 48(4):509-514. PubMed ID: 28752966
[TBL] [Abstract][Full Text] [Related]
16. Hydroxysafflor yellow A attenuate lipopolysaccharide-induced endothelium inflammatory injury.
Jin M; Sun CY; Zang BX
Chin J Integr Med; 2016 Jan; 22(1):36-41. PubMed ID: 26015073
[TBL] [Abstract][Full Text] [Related]
17. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
[TBL] [Abstract][Full Text] [Related]
18. Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats.
Li L; Dong P; Hou C; Cao F; Sun S; He F; Song Y; Li S; Bai Y; Zhu D
J Ethnopharmacol; 2016 Jun; 186():224-233. PubMed ID: 27063983
[TBL] [Abstract][Full Text] [Related]
19. Hydroxysafflor yellow A ameliorates lipopolysaccharide-induced acute lung injury in mice via modulating toll-like receptor 4 signaling pathways.
Liu YL; Liu YJ; Liu Y; Li XS; Liu SH; Pan YG; Zhang J; Liu Q; Hao YY
Int Immunopharmacol; 2014 Dec; 23(2):649-57. PubMed ID: 25466274
[TBL] [Abstract][Full Text] [Related]
20. KLF2 attenuates bleomycin-induced pulmonary fibrosis and inflammation with regulation of AP-1.
Shi J; Zhou LR; Wang XS; Du JF; Jiang MM; Song Z; Han GC; Mai ZT
Biochem Biophys Res Commun; 2018 Jan; 495(1):20-26. PubMed ID: 29079188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
